CCL2 and experimental autoimmune encephalomyelitis: Previous studies showed MSCs inhibited experimental autoimmune encephalomyelitis- (EAE-) derived CD4+ T cell activation by suppressing STAT3 phosphorylation via CCL2, and CCL2−/− MSCs could not ameliorate disease and decrease Th17 cells in EAE mice [19].